Mach-1 Financial Group’s Apellis Pharmaceuticals APLS Stock Holding History

Mach-1 Financial Group’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,672	Closed	-$228K	–	135
2026 Q1	$228K	Buy	+5,672	New	+$122K	0.08%	149

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mach-1 Financial Group's APLS Position: Q2 2026 in Review

Mach-1 Financial Group sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 5,672 shares — an estimated $228K sold.

Mach-1 Financial Group first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $228K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Mach-1 Financial Group reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Mach-1 Financial Group sold 5,672 Apellis Pharmaceuticals shares in Q2 2026, an estimated $228K.
Mach-1 Financial Group first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Mach-1 Financial Group's Apellis Pharmaceuticals position peaked at $228K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Mach-1 Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.